Purchase Order 75N92E24P00048
Award Date 12/25/23
Potential Completion Date 12/24/24
Potential Value $23K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Biltmore Forest, NC 28803, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The National Human Genome Research Institute, a civilian agency within the U.S. Department of Health and Human Services, awarded a $14,896.00 firm fixed-price purchase order to Qiagen, LLC for HGMD DOWNLOAD, RESEARCH USE, LAB services. The contract has an ultimate completion date of November 30, 2024 and was awarded on December 1, 2023. This award does not utilize a set-aside designation. Qiagen, LLC is a division of the international biotechnology company Qiagen N.V. and has provided various...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $32,634.00 firm fixed-price purchase order to Qiagen, LLC, a division of the international life sciences company Qiagen N.V. The contract is for the provision of the Human Gene Mutation Database (HGMD) data download. Qiagen has provided various products and services to support federal agencies' biomedical research, public health, and healthcare programs...
- This is a firm fixed-price purchase order awarded by the National Human Genome Research Institute, a civilian agency under the Department of Health and Human Services, to Qiagen, LLC for the provision of HGMD (Human Gene Mutation Database) download and research use services. The contract has a period of performance from December 25, 2024 to December 24, 2025 with a ceiling value of $24,169.00. The contract is not set aside for any specific business type. Qiagen, LLC is a division of the...
- The Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) awarded a $33,646.00 firm-fixed-price purchase order to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. The contract is for a 1-year license to access the Human Gene Mutation Database, which provides data on approximately 200,000 human genomic mutations. This data supports NIAID's efforts to build a custom bioinformatics...
- The Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases awarded a firm-fixed price purchase order contract to Qiagen, LLC, a division of Qiagen N.V., for $32,634.00. The contract provides one-year access to the Human Gene Mutation Database for clinical use at the NIH Clinical Center to support a custom bioinformatics pipeline for analyzing genomic data from patients enrolled in NIAID clinical protocols. This sole-source...
- This is a $31,481 firm-fixed-price BPA call contract awarded by the National Human Genome Research Institute (NHGRI), a civilian agency under the U.S. Department of Health and Human Services (HHS), to Qiagen, LLC, a subsidiary of the international biotechnology company Qiagen N.V. The contract has an ultimate completion date of April 30, 2017 and does not utilize a set-aside designation. Qiagen is a manufacturer of molecular diagnostics, scientific equipment, and bioinformatics solutions,...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $43,587.50 firm fixed price purchase order to Qiagen, LLC for one catalog item #834083, HGMD Data Download for clinical use by a medium-sized enterprise. The place of performance will be Qiagen's Germantown, Maryland division. The period of performance is January 1, 2024 through November 25, 2024. No set aside designation or subcontractors were indicated....
- This is a $6,702 firm fixed price contract awarded by the National Human Genome Research Institute (NHGRI), which is part of the National Institutes of Health (NIH), to Qiagen, LLC, a foreign-owned, for-profit manufacturer of molecular diagnostics and scientific equipment. The contract is a Blanket Purchase Agreement (BPA) call, with an ultimate completion date of April 30, 2018. Qiagen, LLC is a subsidiary of the parent company Qiagen N.V., which has a significant federal contracting...
- The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a $44,005 purchase order to Qiagen, LLC to procure a QIACUITY ONE, 5PLEX digital PCR system with trade in of a RainDrop digital PCR system. Qiagen, LLC will deliver the requested products and services under a firm fixed price contract running from April 15, 2022 through May 31, 2022. As the parent company, Qiagen N.V. ultimately benefits from this contract to supply...
- The National Human Genome Research Institute (NHGRI), a civilian agency within the U.S. Department of Health and Human Services, has awarded a firm-fixed-price purchase order worth $223,980.33 to Qiagen, LLC for Ingenuity Pathway Analysis (IPA) software. This award does not have a set-aside designation. Qiagen, LLC is a division of the parent company Qiagen N.V., an international provider of sample and assay technologies for biomedical research, public health, and healthcare programs. Through...
The Department of Health and Human Services' National Institutes of Health National Human Genome Research Institute awarded a $23,018 firm fixed price purchase order to Qiagen, LLC for HGMD DOWNLOAD, RESEARCH USE. The contract period is December 25, 2023 through December 24, 2024. Qiagen will provide access to and use of the Human Gene Mutation Database for research purposes under this contract. The place of performance is Qiagen's Biltmore Forest, North Carolina facility. The National Human Genome Research Institute supports genomic research to better understand, diagnose and treat disease, so this contract enables continued access to the HGMD, a key resource for genomic and genetic research.
Generated 12/23/23, 6:40 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $23.0k | 12/12/23 |